Swedish Tech Weekly #319: Northe, Mindler, Dynamic Code, Anocca, TrackPaw Scientific, Curoflow, Fifty, Nrlyze, Edeva, Seaqure labs, EasyScan, Virtual Days, After Class, Favvos, Arkyv, TERASi, and more A selection of the main news from Sweden's startup and tech sector. All – and many more –have previously been covered in more detail in the Swedish Tech News PRO newsletters.

🇸🇪 @swedishtechwkly newsletter #319 week 34, 2025: #Anocca ($46M), #Mindler (€6.7M), #TrackPaw Scientific (€2.3M), @curoflow (€1.9M), #Fifty (€1.4M). By @martinweigert #NordicMade #swedentech #sthlmtech #gbgtech #skanestartups #eastswedentech www.swedishtechnews.com/swedish-tech-weekly-319/

Additional Funding Raises: #Midas $80M Series B; #FiscalNote $75M Post-IPO Debt; #Stark $62M; #Ivix $60M Series B; #TwinHealth $53M SeriesE; #Anocca $46M; #Medallion $43M Series C

Acquisitions: #AccentureSong > #Superdigital; #AIR > #OwensDesign; #Comply365 > #Beams

Swedish biotech gets $46M to run early TCR cell therapy clinical trial Anocca announced Monday that it secured a fresh SEK 440 million — or roughly $46 million — to run an early-stage trial of a cell therapy for KRAS mutant pancreatic cancer. ...

#sthlmtech #biotech company #Anocca, an immunotherapy startup focused on pancreatic cancer, raised around $46M. Mellby Gård led, joined by AMF and Ramsbury. By @endpts endpoints.news/anocca-gets-... #NordicMade #LifeScience

Anocca announces authorisation pancreatic cancer trial - PharmaTimes VIDAR-1 trial marks company's clinical-stage debut

#Anocca #pancreaticcancer #VIDAR1trial #VIDAR1programme#KRASpositiveadvancedpancreaticcancer #ANOC001therapy #KRASG12Vmutation #TCRTcellsolution #nonviralgeneeditedtreatment #pancreaticcancerpatients #oncogenicKRASmutations #pancreaticductaladenocarcinoma
pharmatimes.com/news/anocca-...